After receiving both the ERC Proof-of-Concept and the Swedish Research Council grants, we end 2025 on a very high note, with Paul also being granted the ERC Consolidator for his project 'ImmunhOss'. And what better way to celebrate this important milestone for the entire lab than a champagne shower!

The DENOVOSS Consortium has been granted an EIC Transition grant! In this project, four partners are working together to bring fully engineered but decellularized human cartilage up to clinical standards: Lund University, Dhalion Biotech, Nantes University, and Basel University. We are particularly excited to see Dhalion Biotech significantly extending its portfolio, with the aim to deliver OssiGel as a brand-new class of biomaterial for bone repair.

David presented his project during the Matrix Seminar Series organized at BMC. The title of his presentation was: 'Single-cell multiomic dissection of early endochondral ossification in human BM-MSCs'.

Laura presented her work during the WCMM Friday Club. She introduced her project on the role of the human bone marrow niche in dendritic cell regulation and its implications for AML immunotherapy. Good job Laura!

On March 20th, Camille, Sara and Elia organized a workshop as part of UniStem Day 2026. The objective was to teach high school students how to inject the microfluidic platforms used in the lab. The three groups of students showed high interest in the activity, and they all did a great job!

Elia gave a presentation of his joint work with Camille on the bone marrow-on-a-chip developed for the BuonMarrow Consortium project during the WCMM Research Day 2026. Sara also contributed to the organization of this successful event!

Sara and Laura took part in Science to School 2026, meeting pupils at Filbornaskolan in Helsingborg. They first introduced stem cells to them and tested what they learnt with a quiz. They also discussed about their own journey in science and what they are doing in their current projects. Lastly, the pupils could handle some cell culture lab material, and they could even try to inject some microfluidic chips!

In the beautiful Palma de Mallorca, Paul and Camille had the chance to present the diverse projects carried out in the lab during the TERMIS-EU meeting. This was also an opportunity to meet the BuonMarrow Pathfinder team, which we will very soon host in Lund for the Consortium annual meeting!

The BuonMarrow Consortium gathered in Lund for two productive days of discussions and strategy planning as we enter the final year of the project. Partners came together to share ongoing results, define the next steps for the months ahead, and enjoy a dinner with a sea view in Bjärred!

Laura won the best presentation award at the LUCC Research Day 2026 in Lund for her work entitled 'The human BM niche's role in DC regulation and its implications for AML immunotherapy'. Congratulations Laura!

As the CEO of Dhalion Biotech AB, Alejandro presented the DENOVOSS project and the OssiGel technology during the ATMP Mini-Symposium in Lund. Well done, Alex!

Patricia recently joined the lab. She is currently pursuing a Master's degree in Biomedicine at Lund University and has a background in Biochemistry from the University of Seville. During her internship in the lab, she will study the immunomodulatory role of the bone marrow mesenchymal niche in acute myeloid leukemia and how it shapes the response to a novel dendritic cell-based immunotherapy. Welcome Patricia!

Alex Antill joined the lab as a project assistant. His previous research background focused on computational biology and early hematopoiesis. His research with us will focus mainly on bone regeneration. Welcome Alex!

Paul, Laura and Camille attended the 2026 EHA meeting in Stockholm. Paul gave a talk during the 'Niche effects on stem cells' session and Laura discussed her project during the poster session on Friday. Camille presented her project during the Young EHA Research meeting on Saturday.